Brentuximab-induced hand-foot syndrome in a Hodgkin lymphoma patient

Ann Hematol. 2016 Feb;95(3):509-10. doi: 10.1007/s00277-015-2538-1. Epub 2015 Nov 18.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Brentuximab Vedotin
  • Hand-Foot Syndrome / diagnosis*
  • Hodgkin Disease / diagnosis
  • Hodgkin Disease / drug therapy*
  • Humans
  • Immunoconjugates / adverse effects*
  • Male
  • Middle Aged

Substances

  • Immunoconjugates
  • Brentuximab Vedotin